The University of Chicago Header Logo

Jennifer L. McNeer

Concepts (182)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
2022
366
4.130
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
2019
43
1.570
Why?
Hematologic Diseases
3
2017
79
1.200
Why?
Immunotherapy
2
2020
622
1.030
Why?
Hematopoietic Stem Cell Transplantation
4
2019
877
0.980
Why?
Central Nervous System Diseases
1
2022
52
0.830
Why?
Central Nervous System Neoplasms
1
2022
80
0.790
Why?
Ploidies
1
2019
40
0.690
Why?
Child
16
2022
6869
0.650
Why?
Antineoplastic Agents, Immunological
1
2020
185
0.640
Why?
Immunoglobulins, Intravenous
1
2017
64
0.580
Why?
Lymphoma, Non-Hodgkin
1
2018
261
0.540
Why?
Adolescent
18
2022
8912
0.530
Why?
Immune System Diseases
1
2015
25
0.530
Why?
Burkitt Lymphoma
1
2014
31
0.490
Why?
Kruppel-Like Transcription Factors
1
2014
93
0.470
Why?
Oxides
2
2010
43
0.460
Why?
Arsenicals
2
2010
48
0.460
Why?
Young Adult
16
2021
5924
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2022
2428
0.440
Why?
Folic Acid
1
2011
59
0.400
Why?
Carnitine
2
2021
14
0.370
Why?
MAP Kinase Kinase Kinases
1
2010
41
0.370
Why?
Asparaginase
2
2021
34
0.370
Why?
Child, Preschool
8
2019
3599
0.370
Why?
Humans
33
2022
85695
0.360
Why?
Chemical and Drug Induced Liver Injury
2
2021
62
0.360
Why?
Injections, Spinal
2
2022
44
0.350
Why?
Communicable Diseases
1
2010
63
0.350
Why?
C-Reactive Protein
1
2010
189
0.350
Why?
Antineoplastic Agents
5
2021
2347
0.330
Why?
Infant
5
2019
3033
0.320
Why?
Glucocorticoids
1
2010
345
0.320
Why?
Biomarkers, Tumor
3
2021
1458
0.310
Why?
Polyethylene Glycols
2
2021
362
0.310
Why?
Polymorphism, Genetic
1
2011
819
0.310
Why?
Neoplasms
3
2020
2869
0.310
Why?
Remission Induction
5
2019
721
0.290
Why?
Translocation, Genetic
2
2016
265
0.240
Why?
Male
18
2021
40678
0.240
Why?
Neoplasm Recurrence, Local
2
2021
1291
0.230
Why?
Female
18
2021
44205
0.230
Why?
Prognosis
4
2020
3655
0.230
Why?
Leukemia, B-Cell
1
2022
23
0.210
Why?
Etoposide
2
2019
196
0.210
Why?
Methotrexate
1
2022
249
0.200
Why?
Cytogenetic Analysis
2
2019
71
0.200
Why?
Retrospective Studies
5
2022
8353
0.200
Why?
Survivors
2
2020
225
0.190
Why?
Neoplasm, Residual
2
2019
161
0.180
Why?
Postoperative Complications
1
2010
2170
0.180
Why?
Hematologic Neoplasms
2
2016
327
0.180
Why?
Infant, Newborn
3
2019
2364
0.180
Why?
Anthracyclines
1
2019
37
0.180
Why?
Leukemia, Myeloid, Acute
2
2019
752
0.180
Why?
Disease-Free Survival
2
2019
1203
0.170
Why?
Recurrence
1
2022
1132
0.170
Why?
Leukemia
1
2021
318
0.170
Why?
Cancer Survivors
1
2020
84
0.160
Why?
Hyperbilirubinemia
1
2018
20
0.160
Why?
Adult
12
2021
25458
0.160
Why?
Risk Factors
3
2020
5370
0.160
Why?
Mediastinal Neoplasms
1
2017
45
0.150
Why?
Salvage Therapy
1
2018
232
0.150
Why?
Treatment Outcome
5
2018
7918
0.150
Why?
Point-of-Care Systems
1
2017
141
0.150
Why?
Prevalence
2
2018
1230
0.150
Why?
Chemotherapy-Induced Febrile Neutropenia
1
2016
6
0.140
Why?
Chronic Disease
1
2020
959
0.140
Why?
Blood Culture
1
2016
11
0.140
Why?
Hodgkin Disease
1
2017
176
0.140
Why?
Escherichia coli Infections
1
2016
35
0.140
Why?
Bone Marrow Examination
1
2015
48
0.130
Why?
Radiotherapy
1
2017
326
0.130
Why?
Philadelphia Chromosome
1
2015
37
0.130
Why?
Imatinib Mesylate
1
2015
126
0.130
Why?
Bacteremia
1
2016
99
0.130
Why?
Survival Rate
4
2021
1855
0.130
Why?
Drug Resistance, Neoplasm
1
2018
589
0.130
Why?
Prednisone
2
2017
255
0.130
Why?
Guideline Adherence
1
2016
222
0.120
Why?
U937 Cells
2
2010
32
0.120
Why?
High-Throughput Nucleotide Sequencing
1
2016
450
0.110
Why?
Escherichia coli
1
2016
595
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2018
926
0.110
Why?
Chromosome Aberrations
1
2014
386
0.110
Why?
Protein-Tyrosine Kinases
1
2014
302
0.110
Why?
Leukemia, T-Cell
1
2012
17
0.110
Why?
Stress, Psychological
1
2016
303
0.110
Why?
Pediatrics
1
2017
343
0.110
Why?
Intracellular Signaling Peptides and Proteins
1
2014
377
0.110
Why?
Lymphoma, T-Cell
1
2012
48
0.110
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2012
101
0.100
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
50
0.100
Why?
Transplantation, Homologous
2
2012
995
0.100
Why?
Dithiothreitol
1
2010
26
0.090
Why?
Biomarkers
2
2022
1703
0.090
Why?
Quality of Life
1
2017
1551
0.090
Why?
Acetylcysteine
1
2010
69
0.090
Why?
Tretinoin
1
2010
125
0.090
Why?
Area Under Curve
1
2010
333
0.090
Why?
Fusion Proteins, bcr-abl
2
2022
106
0.090
Why?
Protein Kinases
1
2010
207
0.080
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2010
171
0.080
Why?
Autophagy
1
2010
148
0.080
Why?
Enzyme Activation
1
2010
692
0.080
Why?
Dexamethasone
1
2010
327
0.080
Why?
Drug Administration Schedule
1
2010
917
0.080
Why?
RNA, Small Interfering
1
2010
547
0.080
Why?
Hematopoietic Stem Cells
1
2010
291
0.080
Why?
Age Factors
1
2012
1834
0.080
Why?
Transplantation Conditioning
1
2010
373
0.080
Why?
Graft vs Host Disease
1
2010
364
0.080
Why?
ROC Curve
1
2010
747
0.080
Why?
Proportional Hazards Models
1
2010
856
0.080
Why?
Phosphorylation
1
2010
1099
0.080
Why?
Reactive Oxygen Species
1
2010
475
0.080
Why?
Induction Chemotherapy
2
2021
147
0.070
Why?
Sex Factors
1
2010
1045
0.070
Why?
Predictive Value of Tests
1
2010
1664
0.070
Why?
Cell Line, Tumor
1
2010
2416
0.060
Why?
Genetic Variation
1
2010
1346
0.060
Why?
Mucin-4
1
2022
7
0.050
Why?
Prospective Studies
2
2021
4163
0.050
Why?
United States
3
2021
6589
0.050
Why?
Amino Acid Sequence
2
2016
2061
0.050
Why?
Base Sequence
2
2016
2326
0.050
Why?
Pediatric Obesity
1
2021
22
0.050
Why?
Acute Disease
1
2022
821
0.050
Why?
Feasibility Studies
1
2021
750
0.040
Why?
Molecular Targeted Therapy
1
2021
266
0.040
Why?
Liver Function Tests
1
2018
94
0.040
Why?
Survival Analysis
1
2021
1535
0.040
Why?
Vincristine
1
2017
111
0.040
Why?
Immunohistochemistry
1
2022
1751
0.040
Why?
Vinblastine
1
2017
108
0.040
Why?
Bleomycin
1
2017
98
0.040
Why?
Chromosome Breakpoints
1
2016
15
0.040
Why?
Dacarbazine
1
2017
102
0.040
Why?
Doxorubicin
1
2017
288
0.040
Why?
Cyclophosphamide
1
2017
299
0.040
Why?
Patient Reported Outcome Measures
1
2017
156
0.040
Why?
Needs Assessment
1
2017
154
0.040
Why?
Longitudinal Studies
1
2020
998
0.040
Why?
Disease Progression
1
2021
1519
0.040
Why?
Oncologists
1
2016
35
0.040
Why?
Combined Modality Therapy
1
2020
1657
0.040
Why?
Marital Status
1
2016
40
0.030
Why?
Ultrasonography
1
2018
687
0.030
Why?
Educational Status
1
2016
185
0.030
Why?
Sequence Analysis, RNA
1
2016
216
0.030
Why?
Interviews as Topic
1
2016
318
0.030
Why?
Cohort Studies
1
2021
2739
0.030
Why?
Oncogene Proteins, Fusion
1
2014
128
0.030
Why?
Anxiety
1
2016
275
0.030
Why?
Pilot Projects
1
2016
834
0.030
Why?
Follow-Up Studies
1
2020
3609
0.030
Why?
Liver
1
2018
1225
0.030
Why?
Genes, myc
1
2012
39
0.030
Why?
Chromosomes, Human, Pair 14
1
2012
49
0.030
Why?
Chromosomes, Human, Pair 8
1
2012
85
0.030
Why?
Neoplasm Staging
1
2017
1929
0.030
Why?
Depression
1
2016
452
0.030
Why?
Clinical Laboratory Techniques
1
2012
72
0.030
Why?
World Health Organization
1
2012
102
0.030
Why?
Incidence
1
2016
1562
0.030
Why?
Immunophenotyping
1
2012
211
0.030
Why?
Time Factors
1
2020
5188
0.020
Why?
Bone Marrow Cells
1
2012
251
0.020
Why?
Ubiquitin-Activating Enzymes
1
2010
6
0.020
Why?
Autophagy-Related Protein 7
1
2010
12
0.020
Why?
Beclin-1
1
2010
14
0.020
Why?
Cross-Sectional Studies
1
2016
1589
0.020
Why?
Severity of Illness Index
1
2016
1774
0.020
Why?
MAP Kinase Signaling System
1
2010
192
0.020
Why?
Apoptosis Regulatory Proteins
1
2010
199
0.020
Why?
Microtubule-Associated Proteins
1
2010
176
0.020
Why?
Mice, Knockout
1
2010
1908
0.020
Why?
Aged
1
2021
18258
0.010
Why?
Membrane Proteins
1
2010
1194
0.010
Why?
Mice
1
2010
11195
0.010
Why?
Animals
1
2010
26418
0.010
Why?
McNeer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (182)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_